| Ferrocene‐mediated proton‐coupled electron transfer in a series of ferrocifen‐type breast‐cancer drug candidates E Hillard, A Vessières, L Thouin, G Jaouen, C Amatore Angewandte Chemie 118 (2), 291-296, 2006 | 482 | 2006 |
| Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro A Vessieres, S Top, P Pigeon, E Hillard, L Boubeker, D Spera, G Jaouen Journal of medicinal chemistry 48 (12), 3937-3940, 2005 | 245 | 2005 |
| Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds EA Hillard, FC de Abreu, DCM Ferreira, G Jaouen, MOF Goulart, ... Chemical Communications, 2612-2628, 2008 | 207 | 2008 |
| Bioorganometallics: Future Trends in Drug Discovery, Analytical Chemistry, and Catalysis, EA Hillard, G Jaouen Organometallics 30 (1), 20-27, 2011 | 196 | 2011 |
| Ferrocenyl quinone methides as strong antiproliferative agents: formation by metabolic and chemical oxidation of ferrocenyl phenols P Herson, GØ Jaouen, D Mansuy Angew. Chem 121, 9288-9290, 2009 | 196 | 2009 |
| Ferrocifens and ferrocifenols as new potential weapons against breast cancer A Nguyen, A Vessières, EA Hillard, S Top, P Pigeon, G Jaouen Chimia 61 (11), 716-716, 2007 | 193 | 2007 |
| A [3] ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines D Plazuk, A Vessières, EA Hillard, O Buriez, E Labbé, P Pigeon, ... Journal of medicinal chemistry 52 (15), 4964-4967, 2009 | 150 | 2009 |
| Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects A Vessières, S Top, W Beck, E Hillard, G Jaouen Dalton Transactions, 529-541, 2006 | 148 | 2006 |
| Ferrocene functionalized endocrine modulators as anticancer agents EA Hillard, A Vessieres, G Jaouen Medicinal Organometallic Chemistry, 81-117, 2010 | 144 | 2010 |
| Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior P Pigeon, S Top, A Vessières, M Huché, EA Hillard, E Salomon, G Jaouen Journal of medicinal chemistry 48 (8), 2814-2821, 2005 | 137 | 2005 |
| A series of unconjugated ferrocenyl phenols: prospects as anticancer agents E Hillard, A Vessieres, F Le Bideau, D Plażuk, D Spera, M Huche, ... ChemMedChem: Chemistry Enabling Drug Discovery 1 (5), 551-559, 2006 | 126 | 2006 |
| Observation of symmetry lowering and electron localization in the doublet-states of a spin-frustrated equilateral triangular lattice: Cu3 (O2C16H23)⊙ 1.2 C6H12 B Cage, FA Cotton, NS Dalal, EA Hillard, B Rakvin, CM Ramsey Journal of the American Chemical Society 125 (18), 5270-5271, 2003 | 114 | 2003 |
| Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs G Sava, G Jaouen, EA Hillard, A Bergamo Dalton Transactions 41 (27), 8226-8234, 2012 | 111 | 2012 |
| The first dirhodium tetracarboxylate molecule without axial ligation: new insight into the electronic structures of molecules with importance in catalysis and other reactions FA Cotton, EA Hillard, CA Murillo Journal of the American Chemical Society 124 (20), 5658-5660, 2002 | 94 | 2002 |
| Filling a void: Isolation and characterization of tetracarboxylato dimolybdenum cations FA Cotton, LM Daniels, EA Hillard, CA Murillo Inorganic Chemistry 41 (6), 1639-1644, 2002 | 90 | 2002 |
| In vitro inhibitory properties of ferrocene-substituted chalcones and aurones on bacterial and human cell cultures KN Tiwari, JP Monserrat, A Hequet, C Ganem-Elbaz, T Cresteil, G Jaouen, ... Dalton Transactions 41 (21), 6451-6457, 2012 | 89 | 2012 |
| After 155 years, a crystalline chromium carboxylate with a supershort Cr− Cr bond FA Cotton, EA Hillard, CA Murillo, HC Zhou Journal of the American Chemical Society 122 (2), 416-417, 2000 | 89 | 2000 |
| Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and [3] ferrocenophane tetrasubstituted olefin derivatives against human cancer cells M Goermen, P Pigeon, S Top, EA Hillard, M Huché, CG Hartinger, ... ChemMedChem 5 (12), 2039-2050, 2010 | 86 | 2010 |
| Organometallic diphenols: The importance of the organometallic moiety on the expression of a cytotoxic effect on breast cancer cells EA Hillard, A Vessières, S Top, P Pigeon, K Kowalski, M Huché, G Jaouen Journal of organometallic chemistry 692 (6), 1315-1326, 2007 | 80 | 2007 |
| Deciphering the activation sequence of ferrociphenol anticancer drug candidates P Messina, E Labbé, O Buriez, EA Hillard, A Vessières, D Hamels, S Top, ... Chemistry–A European Journal 18 (21), 6581-6587, 2012 | 79 | 2012 |
